| Literature DB >> 30461269 |
Youchao Deng1, Meng Su1, Dingding Kang1, Xingyun Liu1, Zhongqing Wen1, Yuling Li1, Lin Qiu1, Ben Shen, Yanwen Duan1,2,3, Yong Huang1,3.
Abstract
Platensimycin (PTM), originally isolated from soil bacteria Streptomyces platensis, is a potent FabF inhibitor against many Gram-positive pathogens, such as methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant enterococci. However, the further clinical development of PTM is hampered by its poor pharmacokinetic properties. In this study, 20 PTM derivatives were prepared by Suzuki-Miyaura cross-coupling reactions catalyzed by Pd (0)/C. Compared to PTM, 6-pyrenyl PTM (6t) showed improved antibacterial activity against MRSA in a mouse peritonitis model. Our results support the strategy to target the essential fatty acid synthases in major pathogens, in order to discover and develop new generations of antibiotics.Entities:
Mesh:
Substances:
Year: 2018 PMID: 30461269 PMCID: PMC7110910 DOI: 10.1021/acs.jmedchem.8b01580
Source DB: PubMed Journal: J Med Chem ISSN: 0022-2623 Impact factor: 7.446